has found that hormone levels, measured through blood tests, are an important indicator of whether women will benefit from recently licensed medication for the prevention of breast cancer. Research ...

Erratum: Busulfan Plus Fludarabine Compared With Busulfan Plus Cyclophosphamide for AML Undergoing HLA-Haploidentical Hematopoietic Cell Transplantation: A Multicenter Randomized Phase III Trial The ...

Nearly 300,000 women in England will be offered a preventative pill to help them avoid breast cancer. The drug, anastrozole, has been available for years as a breast cancer treatment, and had already ...

A new study published in The Lancet Oncology discusses the efficacy of anastrozole, a molecule used to prevent breast cancer in postmenopausal women with a high risk of breast cancer. Study: Effect of ...

June 12, 2006 (Atlanta) — Women with breast cancer who are treated with the aromatase inhibitor anastrozole (Arimidex, AstraZeneca) for 5 years can lose 6% to 7% in bone-mineral density (BMD), enough ...

A drug previously used to treat breast cancer is now being offered to high risk women as a preventative measure. It has previously been used to treat breast cancer but has been “repurposed” to prevent ...

The news that the U.K. has approved a preventive drug for post-menopausal women at risk of developing breast cancer wasn’t a shock to breast medical oncologist Abenaa Brewster. But the fact that a ...

Adjunct treatment with anastrozole in children with congenital adrenal hyperplasia (CAH) delays the rate of bone maturation and increases the predicted adult height over 6 years, with no significant ...

Post-menopausal women in the UK who are at a higher risk of breast cancer may soon have wider access to a medicine called anastrozole to reduce their chance of developing it. The drug, which is taken ...